Prediction of graft-versus-host disease in humans by donor gene-expression profiling.
Institute of Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada.
Graft-versus-host disease (GVHD) results from recognition of host antigens by donor T cells following allogeneic hematopoietic cell transplantation (AHCT). Notably, histoincompatibility between donor and recipient is necessary but not sufficient to elicit GVHD. Therefore, we tested the hypothesis that some donors may be "stronger alloresponders" than others, and consequently more likely to elicit GVHD.
PLoS Med. 2007;4(1):e23.
Pubmed ID: 17378698